Hemmings HC, Akabas MH, Goldstein PA, Trudell JR, Orser BA, Harrison NL.
2005.
Emerging molecular mechanisms of general anesthetic action.. Trends Pharmacol Sci. 26(10):503-10.
Albert KA, Hemmings HC, Adamo AIB, Potkin SG, Akbarian S, Sandman CA, Cotman CW, Bunney WE, Greengard P.
2002.
Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia.. Arch Gen Psychiatry. 59(8):705-12.
Fitch W, Smith G, Hunter JM, Reilly CS, Mahajan RP, Hemmings HC.
2023.
The evolution of the British Journal of Anaesthesia: the first 100 years.. Br J Anaesth. 130(1):3-7.
Mayerhofer A, Hemmings HC, Snyder GL, Greengard P, Boddien S, Berg U, Brucker C.
1999.
Functional dopamine-1 receptors and DARPP-32 are expressed in human ovary and granulosa luteal cells in vitro.. J Clin Endocrinol Metab. 84(1):257-64.
Hemmings HC, Shafer SL.
2020.
Further retractions of articles by Joachim Boldt.. Br J Anaesth. 125(3):409-411.
Hemmings HC.
1998.
General anesthetic effects on protein kinase C.. Toxicol Lett. 100-101:89-95.
Hemmings HC, Yan W, Westphalen RI, Ryan TA.
2005.
The general anesthetic isoflurane depresses synaptic vesicle exocytosis.. Mol Pharmacol. 67(5):1591-9.
Hemmings HC, Lambert DG.
2019.
The good, the bad, and the ugly: the many faces of opioids.. Br J Anaesth. 122(6):705-707.
Fisone G, Cheng SX, Nairn AC, Czernik AJ, Hemmings HC, Höög JO, Bertorello AM, Kaiser R, Bergman T, Jörnvall H.
1994.
Identification of the phosphorylation site for cAMP-dependent protein kinase on Na+,K(+)-ATPase and effects of site-directed mutagenesis.. J Biol Chem. 269(12):9368-73.
Gustafson EL, Girault JA, Hemmings HC, Nairn AC, Greengard P.
1991.
Immunocytochemical localization of phosphatase inhibitor-1 in rat brain.. J Comp Neurol. 310(2):170-88.